Delivery Order SPE2DB24D1007-SPE2DB24FBZFY
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,561.98 firm-fixed-price delivery order is for Advair HFA 115-21 MCG Inhaler 12GM, a pharmaceutical product. The award has an ultimate completion date of February 29, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- The federal contract award, with ID SPE2DB20D3304|SPE2DB24FW5B2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,060.08 firm-fixed-price delivery order is for the supply of Advair HFA 115-21 MCG Inhaler 12GM, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The...
- This federal contract award, valued at $3,282.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Advair HFA 115-21 MCG inhalers, a prescription pharmaceutical product. The contract has a period of performance ending on February 6, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
- This federal contract award, with a ceiling value of $3,071.66, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of an Advair HFA 115-21 MCG Inhaler, a pharmaceutical product. This award is a delivery order under the parent company Cencora, Inc.'s Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December...
- This federal contract award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., with the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the delivery of Advair HFA 115-21 MCG Inhaler, a pharmaceutical product, for a ceiling value of $5,492.53. The contract has a completion date of February 29, 2024 and is a firm fixed-price contract. This order is part of Amerisourcebergen's significant...
- This federal contract award, valued at $4,222.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Advair HFA 115-21 MCG Inhaler, a pharmaceutical product, to support military and federal healthcare programs. The contract has an ultimate completion date of May 3, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM, a pharmaceutical product. The contract has a ceiling value of $6,906.06 and is a delivery order under a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc., valued at up to $999,999,999.00. This IDC serves as the primary vehicle for Cencora, Inc....
- The federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Advair HFA 115-21 MCG Inhaler 12GM to the Defense Logistics Agency (DLA). The Firm Fixed Price delivery order, valued at $4,701.81, has an ultimate completion date of March 1, 2024. This contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC enables...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $7,653.68, is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an Ultimate Completion Date of January 30, 2024. This award is associated with a larger Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $2,859.54 firm-fixed-price delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The contract is for the supply of Advair HFA 115-21 MCG Inhaler, a pharmaceutical product, with a completion date of February 15, 2024. This delivery order is part of the larger $999,999,999.00 IDC held by Cencora, Inc. with the DLA Troop Support Medical, which...
- SPE2DB24D1007Indefinite Delivery Contract
- SPE2DB24D1007-SPE2DB24FBZFYDelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,842.81 firm-fixed-price delivery order contract is for the supply of Advair HFA 115-21 MCG Inhaler 12GM, a pharmaceutical product. The contract has a completion date of May 1, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 4/30/24 |